Global demand for hemostasis and tissue sealing agents is expected to surge ahead at a CAGR of 8.5% from 2022 to 2027 and reach a market valuation of US$ 7.6 billion by 2027, says Fact.MR, market research and competitive intelligence provider. The success of a patient’s recovery after a urologic surgery heavily depends on blood loss management. During surgical repair,...